Author Correction: GAPDH controls extracellular vesicle biogenesis and enhances the therapeutic potential of EV mediated siRNA delivery to the brain

Affiliations

• ¹ Department of Paediatrics, University of Oxford, Oxford, OX1 3QX, UK.
• ² Department of Physiology, Anatomy and Genetics, University of Oxford, Oxford, OX1 3QX, UK.
• ³ John van Geest Centre for Brain Repair, Department of Clinical Neurosciences, University of Cambridge, Cambridge, CB2 0PY, UK.
• ⁴ Department of Laboratory Medicine, Clinical Research Center, Karolinska Institutet, 14186, Stockholme, Sweden.
• ⁵ MDUK Oxford Neuromuscular Centre, University of Oxford, Oxford, OX2 9DU, UK.
• ⁶ Department of Physiology, Anatomy and Genetics, University of Oxford, Oxford, OX1 3QX, UK. clive.wilson@dpag.ox.ac.uk.
• ⁷ Department of Paediatrics, University of Oxford, Oxford, OX1 3QX, UK. matthew.wood@paediatrics.ox.ac.uk.
• ⁸ MDUK Oxford Neuromuscular Centre, University of Oxford, Oxford, OX2 9DU, UK. matthew.wood@paediatrics.ox.ac.uk.
• ⁹ Oxford-Harrington Rare Disease Centre, University of Oxford, Oxford, OX2 9DU, UK. matthew.wood@paediatrics.ox.ac.uk.